stocktools

Congress Earnings Insiders Whales Gurus CEO$CEO Net Worth Smart Money Stocks Industries IPOs Short Squeeze Search Filings Market Map Compare Portfolios Crypto Bitcoin Cycles Lab Research Journal Guides Glossary Flashcards Options Max Pain Worth Knowing

Your dashboardDrag your own widgets and tools into place Check stock risksDilution, float, short interest and the paper trail, from EDGAR.Value a stockFiling-backed valuation and screens, with the formulas shown.Plan a tradeSize it, set the stop, and check levels and volume first.Analyze optionsPayoffs at expiry and open interest by strike, delayed and labelled.Track buying activityInsiders, Congress and funds, from the disclosures they must file.Find market eventsEarnings, offerings, IPOs, halts and macro releases.Plan investmentsDividends, compounding and retirement math, projections labelled.Review my tradesYour journal, P&L timeline and hold times. Local-first.All tools85 toolsSearch or filter every calculator and analyzer

Smart Money ▾

Flow overviewWhere the money is moving Congress tradesWhat lawmakers bought and sold Insider buysOfficer and director Form 4s Whales (13F)What institutions hold Guru portfoliosWhat the legends own CEO pay50 CEOsPay vs shareholder return CEO net worthFiling-anchored, cited

AI homeEvery engine, one cited verdict Trade PlannerConviction score to a sized paper plan Research BriefPlain-English read plus auto-SWOT Bull vs BearFour analysts debate the filings Watchlist ScannerRank a whole list by conviction

Earnings calendarWho reports, when — filing-confirmed Offering calendarEvery offering priced in the past month Offering CheckerAny ticker: last announced vs executed offering Do They Need Money?Cash runway — the motive for a raise Dilution ProfileThe whole picture: O/S, warrants, runway, offerings S-3 Shelf CheckerThe means: can they issue shares?

WorkspacesChartsUp to six linked daily charts, 27 studies ScansMulti-day movers, new highs and lows, gaps IPOsIndustriesComparePortfoliosShort SqueezeMarket MapSectors sized by cap, every tile dated SPY Holdings MapAbout 500 companies, sized by the fund’s filed weights Map by SizeFive market-cap bands, each its own map Insider Trading MapForm 4 purchases and sales, sized by dollars Max PainSearch FilingsFull text of every SEC filing since 2001

Prices & sentimentLive prices, market caps and Fear & Greed Bitcoin cyclesEvery 50%+ crash since 2011 Ethereum cyclesEvery 50%+ crash since 2017 BNB cyclesEvery 50%+ crash since 2017 XRP cyclesEvery 50%+ crash since 2017 Solana cyclesEvery 50%+ crash since 2020 CompareTwo coins, side by side Profit calcWhat a position would be worth DCA calcDollar-cost averaging, backtested

Lab homeExperiments and screeners Quant LibraryLatest arXiv q-fin papers, decoded

Worth Knowing177 cited factsThings worth knowing, each traced to a source Collections10 collectionsFounder stories, company origins, market milestones Learning pathsOrdered routes through the guides, ending at a tool GuidesHow filings and the market actually work Glossary395 termsEvery term, defined plainly FlashcardsDrill the terms until they stick OptionsOptions basics and payoff math JournalLog and grade your own trades

/stocks — the workspaceLOADING

Worth Knowing

Before he co-founded NVIDIA, Jensen Huang bussed tables and washed dishes at Denny’s. He has said the discipline of that first job shaped how he runs the company now worth trillions.

Source: Denny’s / NVIDIA historyRead more →All facts

AI-powered research across filings, trades, earnings and more — in one intelligent workspace. Every claim cited to its source.

Research

Stock Workspaces AI Research Custom Research Report Compare Stocks Stock Screener

Who's buying

Congress Trades Insider Trading Whale 13Fs Executive Pay

Market

Earnings Calendar Why Is It Moving?Small-Cap Dashboard Trading Halts IPO Tracker

Learn

All Tools & Calculators Guides Glossary Worth Knowing

Data ageIngestion ledger →

© 2026 StockTools.aiA publisher, not an adviser: we analyze securities, never advise the person — no buy/sell/hold, no ticker ever paid to appear. AI can make mistakes; always check important info.

Pricing Contact Changelog Directory Methodology Feeds Data access Disclaimer Terms Privacy Delete account

PMCB · All filings

PharmaCyte Biotech, Inc. 10-K

Filed 2022-07-28 · Original on SEC.gov

Attached exhibits

EX-4.2 · Indenture or security terms EX-10.40 · Material contract EX-10.41 · Material contract EX-10.42 · Material contract EX-21.1 · Subsidiaries EX-23.1 · Auditor consent

Jump to a section

Whole filing What changed since last time Item 1 · Business Item 1A · Risk Factors Item 2 · Properties Item 3 · Legal Proceedings Item 5 · Market for Registrant’s Common…Item 7 · Management’s Discussion and An…Item 8 · Financial Statements and Suppl…Item 9A · Controls and Procedures

Item 3. Legal Proceedings

ITEM 3. LEGAL PROCEEDINGS

 There is no material litigation currently pending
against us or any of our subsidiaries or to which any of our or our subsidiaries’ property is subject. To our knowledge, there is
no material litigation against any of our officers or directors in their capacity as such, and no such litigation is contemplated by any
governmental authorities.

 ITEM 4. MINE SAFETY DISCLOSURES

 Not applicable.

 83 

 PART II

Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.